5 completed, 3 recruiting, 2 terminated, 1 enrolling by invitation. 8 Not applicable, 2 Phase 2, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 8 | Completed 4, Terminated 2, Unknown 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Enrolling by invitation 1 |
| Phase 1 | 1 | Enrolling by invitation 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Pigmentary Glaucoma: new trials by email Literature Review of Pigmentary Glaucoma trials Research Report on Pigmentary Glaucoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topical Insulin for Glaucoma (TING2) EYED-002 Low Dose (721 U/mL topical insulin), EYED-002 High Dose (1442 U/mL topical insulin), EYED-002 (highest tolerated dose, 12-month) - Open Angle Glaucoma, Primary Open Angle Glaucoma | Phase 1 / Phase 2 | Enrolling by invitation | Stanford University | 90 | 2026-09-10 | 2026-10-13 |
| Clinical Characteristics of Pigmentary Glaucoma and Efficacy Analysis of Ab-interno 120° Trabeculotomy Ab-interno 120° Trabeculotomy - Pigmentary Glaucoma | Recruiting | Zhongnan Hospital | 11 | 2026-04-01 | 2026-07-20 | |
| Quality of Life After Glaucoma Surgery: Evaluating the Patient Perspective Across Surgical Options NEI-VFQ-25 (National Eye Institute Visual Function Questionnaire-25). - Glaucoma Eye, Open-angle Glaucoma | Recruiting | Hospices Civils de Lyon | 132 | 2026-02-23 | 2026-03-16 | |
| Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma iStent infinite trabecular micro-bypass system model iS3, iDose TR (Travoprost intracameral Implant) 75mcg - Open Angle Glaucoma, Pigmentary Glaucoma | Phase 4 | Recruiting | Jonathon Myers | 20 | 2026-01-05 | 2025-11-14 |
| Safety and Effectiveness of the Hydrus Microstent Hydrus Microstent, Ophthalmic surgery - Open Angle Glaucoma, Primary Open Angle Glaucoma | Not applicable | Terminated | Alcon Research | 33 | 2021-12-13 | 2025-01-15 |
| A Novel Argon Laser Iridoplasty for Pigment Dispersion Syndrome Argon Laser Iridoplasty - Pigment Dispersion Syndrome, Pigmentary Glaucoma | Not applicable | Unknown | Fayoum University | 10 | 2021-12-01 | 2022-07-26 |
| IOP and Medication Reduction in MIGS Procedures Glaucoma and Cataract Surgery - Open Angle Glaucoma, Primary Open Angle Glaucoma | Not applicable | Withdrawn | Wills Eye | 2020-01-06 | 2021-02-21 | |
| Minimally Invasive Micro Sclerostomy First in Man Safety and Preliminary Performance Study Minimally Invasive Micro Sclerostomy - Primary Open Angle Glaucoma, Pigmentary Glaucoma | Not applicable | Completed | Sanoculis Ltd | 96 | 2015-02-01 | 2022-11-30 |
| IOP Fluctuations in Patients With Primary Open-angle Glaucoma, Before and After Selective Laser Trabeculoplasty Sensimed Triggerfish - Primary Open Angle Glaucoma, Pigmentary Glaucoma | Not applicable | Completed | Sensimed AG | 23 | 2012-11-01 | 2015-11-17 |
| Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes Hydrus Microstent, iStent Trabecular Micro Bypass - Primary Open Angle Glaucoma, Pseudoexfoliative Glaucoma | Not applicable | Completed | Ivantis, Inc. | 152 | 2012-10-01 | 2019-12-10 |
| Patch Graft Material Safety and Effectiveness in Covering Glaucoma Drainage Device Tube Molteno 3 glaucoma drainage shunt - Primary Open Angle Glaucoma, Primary Angle Closure Glaucoma | Not applicable | Terminated | Wills Eye | 40 | 2010-08-01 | 2016-11-22 |
| Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma PF-03187207 and Latanoprost Vehicle, Latanoprost 0.005% and PF-03187207 Vehicle - Primary Open Angle Glaucoma, Ocular Hypertension | Phase 2 | Completed | Bausch & Lomb Incorporated | 176 | 2007-03-01 | 2020-09-14 |
| Autoimmune Dysregulation in Pigmentary Glaucoma Trabeculectomy, Trabeculectomy and cataract surgery, Cataract surgery - Pigmentary Glaucoma, Primary Open Angle Glaucoma | Not applicable | Completed | University of Oklahoma | 23 | 2006-02-01 | 2023-12-15 |
Glaucoma, Open-Angle (13) · Exfoliation Syndrome (4) · Glaucoma (3) · Glaucoma, Angle-Closure (2) · Cataract (1) · Glaucoma, Neovascular (1) · Glaucoma-Related Pigment Dispersion Syndrome (1) · Low Tension Glaucoma (1) · Ocular Hypertension (1)
Eye Diseases (13) · Ocular Hypertension (12) · Glaucoma (10) · Iris Diseases (4) · Uveal Diseases (4) · Lens Diseases (1) · Optic Nerve Diseases (1)
Cataract Extraction (2) · Insulin (1) · Latanoprost (1) · Ophthalmologic Surgical Procedures (1) · Trabeculectomy (1) · Tutoplast (1)
Wills Eye (2) · Alcon Research (1) · Bausch & Lomb Incorporated (1) · Fayoum University (1) · Hospices Civils de Lyon (1) · Ivantis, Inc. (1) · Jonathon Myers (1) · Sanoculis Ltd (1) · Sensimed AG (1) · Stanford University (1) · University of Oklahoma (1) · Zhongnan Hospital (1)
United States (8) · France (2) · China (1) · Egypt (1) · Israel (1)
Crystal McAfee, MA-HHSA (1) · Daniel Cotlear, MD (1) · Daniel Lee, MD (1) · Dilru Amarasekera, MD (1) · Jean-Philippe Nordmann, MD (1) · Jeffrey L Goldberg, MD PhD (1) · Julian Garcia Feijoo, Prof. Med. (1) · Kenneth Harper (1) · Marlene M Moster, MD (1) · Nan Zhang, doctor (1) · Wen Zeng, doctor (1) · Xuetian Yu (1)